Human renal cell carcinoma inhibits dendritic cell maturation and functions

Urologe - Ausgabe A

Volumn 43, Issue SUPPL. 2, 2004, Pages

  Song, E Y ^a   Shurin, M R ^a   Tourkova, I L ^a   Chatta, G ^a   Shurin, G V ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Clinical Immunopathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

CANCER SURGERY; CELL ADHESION; CELL CULTURE; CELL FUNCTION; CELL INTERACTION; CELL LINE; CELL MATURATION; CELL MIGRATION; CHEMOTAXIS; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; T LYMPHOCYTE;

ANTIGEN PRESENTATION; CARCINOMA, RENAL CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOTAXIS; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; KIDNEY NEOPLASMS; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 4744371336     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-004-0599-1     Document Type: Conference Paper

References (16)

1. Rini BI, Stadler WM, Spielberger RT, Ratain MJ, Vogelzang NJ (1998) Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma: a phase II trial. Cancer 82:1352-1358
2. Ringhoffer M, Gschwend JE (2002) Spezifische zellulare Immuntherapie des Nierenzellkarzinoms. Stand und Perspektiven. Urologe (Ausg. A) 41:249-257
3. Ng CS, Novick AC, Tannenbaum CS, Bukowski RM, Finke JH (2002) Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NFkappaB suppression. Urology 59:9-14
4. Kudo D, Rayman P, Horton C, Cathcart MK, Bukowski RM, Thornton M, Tannenbaum C, Finke JH (2003) Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells. Cancer Res 63:1676-1683
5. Shurin MR (1996) Dendritic cells presenting tumor antigen. Cancer Immunol Immunotherapy 43:158-164
6. Byrne SN, Halliday GM (2002) Dendritic cells: making progress with tumour regression? Immunol Cell Biol 80:520-530
7. Becker Y (1992) Anticancer role of dendritic cells (DC) in human and experimental cancers - a review. Anticancer Res 12:511-520
8. Shurin MR, Gabrilovich DI (2001) Regulation of dendritic cell system by tumor. Cancer Res Ther Control 11:6S-78
9. Troy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN (1998) Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 4:585-593
10. Troy AJ, Davidson PJ, Atkinson CH, Hart DN (1999) CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated. J Urol 161:1962-1967
11. Aalamian M, Pirtskhalaishvili G, Nunez A, Esche C, Shurin GV, Huland E, Huland H, Shurin MR (2001) Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate 46:68-75
12. Gabrilovich D.Virmani A, Ratnani I, Girgis KR, Nadaf-Rahrov S, Fernandez-Vina M, Carbone DP, Kavanaugh DY (1996) Immunologic dysfunction in cancer, Int J Cancer 67:756-763
13. Thurnher M, Rieser C, Holtl L, Papesh C, Ramoner R, Bartsch G (1998) Dendritic cell-based immunotherapy of renal cell carcinoma. Urologia Int 61:67-71
14. Holtl L, Rieser C, Papesh C, Ramoner R, Bartsch G, Thurnher M (1998) CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer. Lancet 352:1358
15. Holtl L, Rieser C, Papesh C, Ramoner R, Herold M, Klocker H, Radmayr C, Stenzl A, Bartsch G, Thurnher M (1999) Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol 161:777-782
16. Kleindienst P, Brocker T (2003) Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J Immunol 170:2817